- Will Schilling pitch at all and if he does, will he be any good?
- Will Beckett’s back be an issue all year?
- Will Dice-K be any better than he was last year?
- Can Wakefield’s balky back hold up to added work?
- Will Colon be able to duct-tape his shoulder together to get anything out of it?
- Will Lester be anything more than a #3?
- Will Buchholz be expected to pitch 200 IP? Can he handle that, if required? He’s gotten shelled during Spring Training, FWIW.
- May 17, 2007: Finger injury, 15-day DL.
- May 14, 2007: Finger injury, day-to-day.
- Oct 4, 2005: Missed the last 17 games of the regular season.
- Oct 2, 2005: Missed 8 games to the end of the regular season (shoulder injury).
- Sep 28, 2005: Shoulder injury, day-to-day.
- Sep 15, 2005: Achilles tendon, day-to-day.
- Jul 30, 2005: Missed 14 games (lower back strain).
But, while we all knew it’s true, it’s particularly eye-opening to read just how complicity both sides of MLB are in this mess, Union and Management (emphasis mine):
Even when physicians and trainers began to raise the issue of performance-enhancing drugs in the late 1980s, baseball’s sentinels were either unwilling to tackle the problem or unable to find an approach they could agree on, baseball insiders said.
“At one of those [offseason] meetings, a team physician stood up and said, ‘We have a problem, and the problem has to do with possible drugs that are being used by athletes and players, and the only way we can deal with this problem is through testing,‘” says Larry Starr, a team athletic trainer for 30 years with the Cincinnati Reds and Florida Marlins. “The basic feedback from that meeting and subsequent meetings for a number of years after that was, from the owner’s group, ‘We agree: We need to do testing.